Corpus Intelligence IC Memo — FLEMING COUNTY HOSPITAL 2026-04-26 09:55 UTC
IC Memo — FLEMING COUNTY HOSPITAL
Investment Committee Memorandum | KY | 25 beds | Grade C | EBITDA uplift $1.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

FLEMING COUNTY HOSPITAL

CCN 181332 | FLEMING, KY | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

FLEMING COUNTY HOSPITAL is a 25-bed suburban community hospital in FLEMING, KY with $20.8M in net patient revenue and a 6.0% operating margin. The hospital serves a payer mix of 37.2% Medicare, 0.4% Medicaid, and 62.4% commercial.

Thesis: Turnaround. Our ML models identify $1.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 6.0% to 13.4% (+736bps).

Net Revenue HCRIS$20.8M
Current EBITDA COMPUTED$1.3M
Operating Margin COMPUTED6.0%
Occupancy HCRIS34.0%
Revenue / Bed COMPUTED$833K
Net-to-Gross HCRIS30.3%
Distress Probability ML51.6%

2. Market Context & Competitive Position

114
KY Hospitals
-0.6%
State Median Margin
54
Comparable Hospitals

KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 6.0% places it above the state median. Among 54 size-comparable peers (12-50 beds), the median margin is -2.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 54 hospitals in the comp set.

HospitalStateBedsRevenueMargin
FLEMING COUNTY HOSPITAL (Target)KY25$20.8M6.0%
BAPTIST HEALTH LAGRANGEKY42$236.9M2.7%
FLAGET MEMORIAL HOSPITALKY40$86.2M-0.6%
ROCKCASTLE HOSPT. & RESPIR CARKY30$79.1M2.2%
ADVENTHEALTH MANCHESTERKY49$73.0M-11.0%
HARRISON MEMORIAL HOSPITALKY34$67.8M-9.9%
SAINT JOSEPH MOUNT STERLINGKY42$64.2M-5.4%
OHIO COUNTY HOSPITALKY25$56.6M-6.8%
OWENSBORO HEALTH TWIN LAKES MEKY49$55.2M14.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$437K+210bp18mo
Cost to Collect4.5%2.5%$416K+200bp12mo
Denial Rate Reduction12.0%6.5%$412K+198bp12mo
A/R Days Reduction5200.0%3800.0%$253K+122bp9mo
Clean Claim Rate88.0%96.0%$13K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$437K
Cost to Collect
$416K
Denial Rate Reduction
$412K
A/R Days Reduction
$253K
Clean Claim Rate
$13K
Total EBITDA Uplift$1.5M
Current EBITDA$1.3M
+ RCM Uplift+$1.5M
Pro Forma EBITDA$2.8M
Current Margin6.0%
Pro Forma Margin13.4%
WC Released (1x)$799K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.9M$23.6M12.21x64.9%
Base (11x exit)10.0x11.0x$1.9M$26.6M13.75x68.9%
Bull Case9.0x11.0x$1.7M$32.3M18.55x79.3%
Bull (12x exit)9.0x12.0x$1.7M$35.7M20.53x83.0%
Bear Case11.0x10.0x$2.1M$15.3M7.20x48.4%
Bear (11x exit)11.0x11.0x$2.1M$17.6M8.25x52.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 34.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 51.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 54 hospitals with 12-50 beds
  • Same-state prioritization (n=55)
  • Comp margins: P25=-11.0% / P50=-2.8% / P75=6.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.